The IMID Forum
Discussing axSpA: Biologic therapy outcomes in axial spondyloarthritis
May 15, 2026·21 min
Episode Description from the Publisher
Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered how certolizumab pegol reduces anterior uveitis flares in high-risk axSpA and the effect of secukinumab dose escalation on MRI inflammation and damage in axSpA.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Get Free Summaries →
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
Get summaries like this every morning.
Free AI-powered recaps of The IMID Forum and your other favorite podcasts, delivered to your inbox.
Get Free Summaries →
Free forever for up to 3 podcasts. No credit card required.